Grace appeals to gov’t to monitor all children given Sanofi’s dengue vaccine
Health officials must “focus” on children who were given the controversial Dengavaxia vaccine shots to prepare for any symptoms from the vaccine’s side effects.
Sen. Grace Poe made the call amid reports that there might be increased risk for people who were administered the vaccine but not previously infected with the mosquito-borne virus.
“It is important to account for children who received the vaccine amid new developments on its effects (on those who have not yet been sick with dengue),” she said.
“Strict surveillance must be established to monitor any adverse effects and ensure that proper assistance will be given to those affected,” Poe said.
Dengvaxia developer Sanofi Pasteur admitted that the vaccine—despite being commercially available— was not recommended for those without prior infection of dengue came a year after foreign health experts warned of potentially higher risks if the vaccine is not administered correctly.
This prompted the Department of Health (DoH) to suspend the sale, distribution and the ongoing vaccinations, and lawmakers to call for far-reaching investigation into the P3.5 billion program.